pharmaphorum editor in chief Jonah Comstock takes on the Health Innovators series with a conversation with Amy Bucher, chief behavioral officer at Lirio and author of “Engaged: Designing fo
For years, digital health has been heralded as the saviour of health services and the answer to patient engagement. Now the conversation is changing from what technology can do, to wha
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh